| 产品详情 |
| Edit |   |
|---|
| Product Name | RWJ-67657 |
|---|
| Description | RWJ-67657 is a potent inhibitor of the MAP kinases p38α and p38β (IC50s = 1 and 11 µM, respectively, in vitro); inactive against p38γ and p38δ, as well as several other kinases. RWJ-67657 blocks the release of TNF-α and IL-1β from peripheral blood mononuclear cells stimulated with LPS (IC50s = 3 and 11 nM, respectively) and inhibits TNF-α production in LPS-treated mice and rats. MW: 425.5. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol |
|---|
| Gene, Accession, CAS # | CAS: 215303-72-3 |
|---|
| Catalog # | B2098-5 |
|---|
| Price | |
|---|
| Order / More Info | RWJ-67657 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|